The clinicopathologic relevance of RECK gene polymorphisms in ameloblastoma
- 15 March 2017
- journal article
- Published by Elsevier in Archives of Oral Biology
- Vol. 79, 77-86
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A hypothesis for the role of RECK in angiogenesisCurrent Vascular Pharmacology, 2015
- MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatisCancer Epidemiology, Biomarkers & Prevention, 2015
- Activation of Toll-like Receptor-2 by Endogenous Matrix Metalloproteinase-2 Modulates Dendritic-Cell-Mediated Inflammatory ResponsesCell Reports, 2014
- Novel Targets for the Treatment of AmeloblastomaJournal of Dental Research, 2014
- Reversion‐Inducing‐Cysteine‐Rich Protein With Kazal Motifs (RECK) Gene Single Nucleotide Polymorphism With Hepatocellular Carcinoma: A Case–Control StudyJournal of Clinical Laboratory Analysis, 2014
- VEGF and MMP‐9: biomarkers for canine lymphomaVeterinary and Comparative Oncology, 2012
- Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in TaiwanCarcinogenesis, 2011
- RECK in osteosarcomaCancer, 2011
- RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancerCancer and Metastasis Reviews, 2007
- Establishment of the genomic structure and identification of thirteen single-nucleotide polymorphisms in the human RECK geneCytogenetic and Genome Research, 2002